VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 137 filers reported holding VERVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,455,407 | -24.3% | 3,277,180 | +7.0% | 0.00% | -33.3% |
| Q2 2023 | $57,431,850 | +18.9% | 3,063,032 | -8.6% | 0.00% | 0.0% |
| Q1 2023 | $48,303,784 | -72.1% | 3,349,777 | -62.5% | 0.00% | -40.0% |
| Q4 2022 | $173,029,596 | +79.9% | 8,942,098 | +219.4% | 0.01% | -16.7% |
| Q3 2022 | $96,174,000 | +939.8% | 2,799,834 | +362.6% | 0.01% | +500.0% |
| Q2 2022 | $9,249,000 | -84.8% | 605,283 | -77.3% | 0.00% | -66.7% |
| Q1 2022 | $60,772,000 | -6.5% | 2,663,106 | +51.0% | 0.00% | 0.0% |
| Q4 2021 | $65,015,000 | +478.8% | 1,763,364 | +637.8% | 0.00% | +200.0% |
| Q3 2021 | $11,233,000 | – | 239,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |